APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 249 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,064,165 | -84.2% | 54,263 | -62.2% | 0.01% | -83.9% |
| Q2 2023 | $13,063,922 | +199.0% | 143,402 | +116.5% | 0.06% | +181.8% |
| Q1 2023 | $4,368,861 | -40.5% | 66,235 | -38.4% | 0.02% | -45.0% |
| Q3 2022 | $7,339,000 | +96.7% | 107,452 | +46.3% | 0.04% | +90.5% |
| Q1 2022 | $3,731,000 | +3.6% | 73,426 | -3.6% | 0.02% | +5.0% |
| Q4 2021 | $3,601,000 | -68.7% | 76,162 | -78.2% | 0.02% | -73.0% |
| Q3 2021 | $11,493,000 | +17.5% | 348,708 | +125.3% | 0.07% | +8.8% |
| Q2 2021 | $9,783,000 | +2064.4% | 154,799 | +1859.2% | 0.07% | +1600.0% |
| Q4 2020 | $452,000 | -11.9% | 7,901 | -52.9% | 0.00% | -60.0% |
| Q4 2019 | $513,000 | +123.0% | 16,762 | +42.1% | 0.01% | +42.9% |
| Q1 2019 | $230,000 | – | 11,798 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
| Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
| Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
| Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
| Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
| ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
| Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
| Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
| venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
| HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |